Bank of Montreal’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
Other funds holding MCRB
FP
AIM
NAMA
GGHC
Bank of Montreal's MCRB Position: Q2 2021 in Review
Bank of Montreal sold out of Seres Therapeutics (MCRB) in Q2 2021, closing a stake of 125 shares — an estimated $51K sold.
Bank of Montreal first reported a position in MCRB in Q3 2016 and held it in 18 quarters. The position peaked at $1.51M in Q3 2020. 146 funds tracked by Wall St. Rank hold MCRB as of Q2 2021.
- Bank of Montreal reported no remaining Seres Therapeutics position as of Q2 2021 after selling out during the quarter.
- Bank of Montreal sold 125 Seres Therapeutics shares in Q2 2021, an estimated $51K.
- Bank of Montreal first reported a position in Seres Therapeutics in Q3 2016 and held it in 18 quarters.
- Bank of Montreal's Seres Therapeutics position peaked at $1.51M in Q3 2020.
- 146 funds tracked by Wall St. Rank held Seres Therapeutics as of Q2 2021.
Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.